Sidra Medicine wins seal of approval from Joint Commission International
February 12 2020 09:35 PM
Dr Abdulla al-Kaabi and Mohamed K al-Mana receiving the official JCI certificate.
Dr Abdulla al-Kaabi and Mohamed K al-Mana receiving the official JCI certificate. President and CEO of the Joint Commission Dr Mark R Chassin, President and Chief Executive Officer of Joint Commission Resources Paula Wilson officially presented the JCI Gold Seal of Approval to Sidra Medicine at a ceremony on February 10.

QNA/Doha

Sidra Medicine, a member of Qatar Foundation (QF), has been awarded the Joint Commission International's Gold Seal of Approval for its hospital and academic medical centre.
Sidra Medicine was commended for its efforts to become a quality improvement organisation, and demonstrating a commitment to patient safety and quality.
President and CEO of the Joint Commission Dr Mark R Chassin, President and Chief Executive Officer of Joint Commission Resources Paula Wilson officially presented the JCI Gold Seal of Approval to Sidra Medicine at a ceremony on 10th February 2020. Managing Director for Joint Commission International, Middle East and Africa Murat Kucukkaya was also present.
On the occasion, Dr Chassin gave a presentation on what it takes to become a High Reliability Organisation as part of the next phase after becoming JCI accredited. He highlighted the importance of integrating process improvement measures, governance, financial planning, and quality strategy and priorities effectively.
The ceremony was chaired by Chair of the Transition Committee and Member of the Board of Governors at Sidra Medicine Mohamed K al-Mana, and Chief Medical Officer and Executive Lead for Sidra Medicine's JCI Accreditation Dr Abdulla al-Kaabi. The event also featured several board members and representatives from partner healthcare organisations including the Ministry of Public Health; Hamad Medical Corporation including its Ambulance service; Primary Health Care Corporation and Aspetar.
The receipt of the JCI accreditation follows a successful survey of the hospital's facilities, patient-safety processes and as an academic medical centre in November 2019. Sidra Medicine has been preparing for JCI accreditation since opening its main hospital in January 2018.
Chief Medical Officer and Executive Lead for Sidra Medicine's JCI Accreditation at Sidra Medicine Dr Abdulla al-Kaabi said: "This time two years ago, we celebrated the official opening of our main hospital with the world. And now we have cause to celebrate another important milestone, receiving the academic accreditation from JCI. It is a particularly significant achievement for a Greenfield hospital like ours to meet the highest standards of safe clinical care, research practices and medical education, within two years of becoming fully operational. The JCI accreditation is a testament of our commitment to delivering high quality care, putting our patients safety first as well as advancing medical education."
At the ceremony, Dr Abdulla added: "This award doesn't belong to a single person or a single team. It belongs to all of us, because we all had a part to play in achieving this accreditation. Qatar will be proud of many institutions it has built to empower its people. The prosperity of a country relies on the good health of its people. I have no doubt in my mind that Sidra Medicine will be recognised as one of those institutions."
Performed by an interdisciplinary clinical team of five JCI surveyors, the evaluation at Sidra Medicine in November 2019 covered in-depth assessments across all areas to ensure the hospitals compliance regarding the safety and quality of its medical treatment, as well as the environment in which treatment was performed. The evaluation also covered Sidra Medicine's research facilities, publications as well as its medical education strategy and processes among others.
Sidra Medicine was commended on the state of its facilities, the knowledge and dedication of its multi-disciplinary and diverse teams. Its clinical programmes, such as the perinatal mental health services, Neonatal Pediatric Intensive Care (NICU), radiology, pharmacy and laboratory services and processes were also commended. The processes and experience of the hospitals Infection Control team was applauded as outstanding by the surveyors in addition to the organisations commitment to continuous quality improvement to ensuring it delivers safe patient care.
Al-Mana said: "On behalf of the management at Sidra Medicine, I would like to thank all of our staff who have rigorously worked towards Sidra Medicine achieving this milestone. Receiving the gold seal is an affirmation of our dedication to continuous improvement towards safety for patients and families in Qatar as well as building on our research activities and academic programmes for healthcare professionals."



There are no comments.

LEAVE A COMMENT Your email address will not be published. Required fields are marked*
MORE NEWS